Half-year report · Q2
3583.TEDINET S100UOJ8
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥5.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥489m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥270m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥454m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥601m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥294m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥452m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥294m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥436m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥218m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥218m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥9.6bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥9.7bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥9.5bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.1bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥3.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.5bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.0bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥313m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥601m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥202m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥165m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥99m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥391m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥451m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥139m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥108.1 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥156.8 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.21 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 67.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥817m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥817m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥65m |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥598m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥663m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥663m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥721m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥720m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥645,000 |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥48m |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥382m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.6bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.6bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥645,000 |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥430m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥645,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥430m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 518
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人グラヴィタス | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)藤 本 良 治 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)飯 田 一 紀 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 2622286000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 2991292000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 5387010000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 293902000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 453726000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 600779000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 217535000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 302335000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 436435000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 241475000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 292558000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 479629000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 6018540000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 6509308000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6256646000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 9540877000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 9625248000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 9721703000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 78.21 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 108.10 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 156.80 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.631 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.676 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.644 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 601298000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 312639000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1054683000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -99225000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -202285000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -164645000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -138841000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -391438000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -450598000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 2758862000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 2548041000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 2840544000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3092623 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3092623 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 3092623 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 3092623 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 471000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1530 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |